Literature DB >> 16703268

Regional influences on the dispensing of glucose test strips in Dutch community pharmacies.

Michiel J Storimans1, Olaf H Klungel, Herre Talsma, Cornelis J de Blaey.   

Abstract

BACKGROUND: Pharmacy practice guidelines promote the role of community pharmacies in self-monitoring of blood glucose. However, variations between Dutch pharmacies exist in the proportion of patients to whom test strips are dispensed.
OBJECTIVE: To assess whether variations between community pharmacies in dispensing of blood glucose test strips can be explained by differences in patient characteristics and the region in which the pharmacy is located.
SETTING: PHARMO-Record Linkage System containing drug dispensing histories from 40 community pharmacies of about 450,000 patients in the Netherlands.
METHOD: We performed a retrospective cohort study. Data on prescription of all drugs and medical aids between 1991 and 2001 were extracted for all new users of antidiabetic drugs. Patients were excluded if the dispensing history did not allow classification of the type of diabetes or if the dispensing pharmacy could not be determined. The data were analysed using a Cox proportional hazard model. MAIN OUTCOME MEASURE: Time to first test strips dispensed.
RESULTS: We identified 8,233 starters of antidiabetic drugs. During a median follow-up of 2.1 years, 20% of the patients were dispensed test strips at least once. Community pharmacy was significantly associated with the dispensing of test strips after adjustment for patient characteristics. This association was less apparent when stratified for the geographical location of the pharmacy.
CONCLUSION: Community pharmacy is an independent determinant of the start of use of test strips. Differences in dispensing of test strips between pharmacies are dependent on geographical region. This suggests that implementing practice guidelines for diabetes care in community pharmacy requires different approaches in different regions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16703268     DOI: 10.1007/s11096-005-2908-1

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  20 in total

1.  Epidemiology and determinants of blood glucose self-monitoring in clinical practice.

Authors:  N Scorpiglione; M el-Shazly; M Abdel-Fattah; M Belfiglio; D Cavaliere; F Carinci; D Labbrozzi; E Mari; M Massi Benedetti; G Tognoni; A Nicolucci
Journal:  Diabetes Res Clin Pract       Date:  1996-10       Impact factor: 5.602

2.  The Asheville Project: short-term outcomes of a community pharmacy diabetes care program.

Authors:  Carole W Cranor; Dale B Christensen
Journal:  J Am Pharm Assoc (Wash)       Date:  2003 Mar-Apr

3.  The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program.

Authors:  Carole W Cranor; Barry A Bunting; Dale B Christensen
Journal:  J Am Pharm Assoc (Wash)       Date:  2003 Mar-Apr

4.  Outcomes of a community pharmacy-based diabetes monitoring program.

Authors:  R Berringer; M C Shibley; C C Cary; C B Pugh; P A Powers; J A Rafi
Journal:  J Am Pharm Assoc (Wash)       Date:  1999 Nov-Dec

5.  Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project.

Authors:  G T O'Connor; H B Quinton; N D Traven; L D Ramunno; T A Dodds; T A Marciniak; J E Wennberg
Journal:  JAMA       Date:  1999-02-17       Impact factor: 56.272

6.  Barriers to blood glucose monitoring in a multiethnic community.

Authors:  Janice C Zgibor; David Simmons
Journal:  Diabetes Care       Date:  2002-10       Impact factor: 19.112

7.  Dispensing glucose test materials in Dutch community pharmacies.

Authors:  Michiel J Storimans; Herre Talsma; Olaf H Klungel; Cornelis J de Blaey
Journal:  Pharm World Sci       Date:  2004-02

8.  Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme.

Authors:  R M Herings; A de Boer; B H Stricker; H G Leufkens; A Porsius
Journal:  Lancet       Date:  1995-05-13       Impact factor: 79.321

9.  Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life.

Authors:  R M Herings; B H Stricker; A de Boer; A Bakker; F Sturmans
Journal:  Arch Intern Med       Date:  1995-09-11

10.  Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic.

Authors:  Seth T Cioffi; Michael F Caron; James S Kalus; Patricia Hill; Thomas E Buckley
Journal:  Ann Pharmacother       Date:  2004-03-18       Impact factor: 3.154

View more
  1 in total

1.  Correlating pharmaceutical data with a national health survey as a proxy for estimating rural population health.

Authors:  Ronald E Cossman; Jeralynn S Cossman; Wesley L James; Troy Blanchard; Richard Thomas; Louis G Pol; Arthur G Cosby
Journal:  Popul Health Metr       Date:  2010-09-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.